Next, we performed real-time PCR to measure the expression levels of YAP target genes CTGF and CYR61 in multiple cancer cell lines, including T47D, A549, and HepG2, following treatment with the five selected drugs (Figure 3C-E). This evidence concerns the gene CCN2 and cancer.